In-Person Access Only | TBD CE/CME Credits & MOC Points

Please read:All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $25 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com

The 2026 Liver Cancer Symposium will address the ongoing public health crisis of liver malignancies. Key topics that will be discussed at this conference include:

• Emerging treatments (including new medications and the role of molecular biology and genetic testing in personalizing therapy)

• Essential updates on the latest diagnostic and treatment methodologies

This accredited meeting will be hosted as an in-person conference only.

Conference Agenda
Friday, December 4, 2026

7:30 AM
Coffee and Exhibits

8:00 AM
Program Chair Welcome

8:05 AM
Executive Leadership Welcome

8:15 AM
Session Topic

8:45 AM
Session Topic

9:15 AM
Session Topic

9:45 AM
Breakfast and Exhibits

10:00 AM
Non-CME Breakfast

10:45 AM
Session Topic

11:15 AM
Session Topic

11:45 AM
Session Topic

12:15 PM
Lunch and Exhibits

1:00 PM
Non-CME Lunch

1:45 PM
Session Topic

2:15 PM
Session Topic

2:45 PM
Session Topic

3:15 PM
Session Topic

3:45 PM
Break and Exhibits

4:00 PM
Session Topic

4:30 PM
Session Topic

5:00 PM
Session Topic

5:30 PM
Closing Remarks

5:35 PM
ADJOURN

Agenda Subject To Change. All times are EST.

• Learning Objectives

  Review and analyze advances in the treatment of liver cancers including newly available clinical trials.
  
  Identify specific clinical trials available to liver cancer patients at different stages of their disease process.
  
  Describe specific molecular or genetic mutations found in liver cancers that would indicate use of a specific medication to treat the disease.

• Accreditation Information | TBD

• What to Expect | In-Person Learners

  • Free registration for all healthcare providers

  • Expert sessions that present the most clinically relevant data, research, and clinical strategies

  • Real-time discussion and debate

  • Networking with peers, colleagues, and medical professionals

  • Access to the latest industry information and resources

  • Catered meals through-out the program